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Bovine and camel chymosin are aspartic peptidases that are
used industrially in cheese production. They cleave the
Phe105-Met106 bond of the milk protein -casein, releasing
its predominantly negatively charged C-terminus, which leads
to the separation of the milk into curds and whey. Despite
having 85% sequence identity, camel chymosin shows a 70%
higher milk-clotting activity than bovine chymosin towards
bovine milk. The activities, structures, thermal stabilities and
glycosylation patterns of bovine and camel chymosin obtained
by fermentation in Aspergillus niger have been examined.
Different variants of the enzymes were isolated by hydro-
phobic interaction chromatography and showed variations
in their glycosylation, N-terminal sequences and activities.
Glycosylation at Asn291 and the loss of the first three residues
of camel chymosin significantly decreased its activity. Thermal
differential scanning calorimetry revealed a slightly higher
thermal stability of camel chymosin compared with bovine
chymosin. The crystal structure of a doubly glycosylated
variant of camel chymosin was determined at a resolution of
1.6 A˚ and the crystal structure of unglycosylated bovine
chymosin was redetermined at a slightly higher resolution
(1.8 A˚) than previously determined structures. Camel and
bovine chymosin share the same overall fold, except for the
antiparallel central -sheet that connects the N-terminal and
C-terminal domains. In bovine chymosin the N-terminus
forms one of the strands which is lacking in camel chymosin.
This difference leads to an increase in the flexibility of the
relative orientation of the two domains in the camel enzyme.
Variations in the amino acids delineating the substrate-binding
cleft suggest a greater flexibility in the ability to accommodate
the substrate in camel chymosin. Both enzymes possess local
positively charged patches on their surface that can play a role
in interactions with the overall negatively charged C-terminus
of -casein. Camel chymosin contains two additional positive
patches that favour interaction with the substrate. The
improved electrostatic interactions arising from variation in
the surface charges and the greater malleability both in
domain movements and substrate binding contribute to the
better milk-clotting activity of camel chymosin towards bovine
milk.
Received 19 November 2012
Accepted 31 January 2013
PDB References: bovine
chymosin, 4aa8; camel
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1. Introduction
Cheese production represents one of the earliest biotechno-
logical applications of enzymes (Szecsi, 1992). Presumably,
the first cheese production was merely an unexpected conse-
quence of storing milk in bags made from the stomachs of
ruminants (Tamime, 1993). The active ingredients in this
process were identified as the proteolytic enzymes pepsin and
chymosin, previously referred to as ‘rennet’ (Foltmann, 1966),
in the early days of protein science (Fruton, 2002).
Both chymosin and pepsin belong to the pepsin-like family
of aspartic peptidases (family A1 using the MEROPS classi-
fication; http://merops.sanger.ac.uk; Rawlings et al., 2010) and
their sequences are 55% identical. The inactive proenzymes
contain an N-terminal prosegment of around 42 residues
which is removed upon secretion into the acidic environment
of the stomach, thereby leading to activation (Szecsi, 1992).
Structural information is available for several members of the
aspartic peptidase family. The crystal structures of porcine
pepsin as a proenzyme (Sielecki et al., 1991; Hartsuck et al.,
1992) and as an active enzyme (Cooper et al., 1990; Sielecki et
al., 1990) are known. Structures have also been determined of
native bovine chymosin (Gilliland et al., 1990; Newman et al.,
1991), a mutant of bovine chymosin (Strop et al., 1990) and an
inhibitor complex (Groves et al., 1998).
Pepsin and chymosin display the same overall structure,
which is mainly comprised of -sheets forming two similarly
folded barrel domains. Structural comparisons have revealed
repeating elements between and within each domain, which
suggests gene duplications (Tang et al., 1978). The substrate-
binding cleft and active site are located at the interface of the
two domains. An antiparallel -sheet referred to as the central
sheet (Sˇali et al., 1992) connects the two domains and consti-
tutes an independent structural element. The active site
contains an activated water molecule held in position by two
Asp residues: one from each domain (Cooper et al., 1990;
Gilliland et al., 1990; Sielecki et al., 1990; Newman et al., 1991).
The positions of the two catalytic Asp residues are secured
through hydrogen-bond interactions with adjacent residues,
forming an interdomain network referred to as the ‘fireman’s
grip’ (Pearl & Blundell, 1984; Newman et al., 1991). The
catalytic mechanism proposed by Suguna et al. (1987) and
James et al. (1992) involves a series of proton transfers trig-
gered by nucleophilic attack of the water molecule between
the two Asp residues. This proposed mechanism has recently
been supported by neutron diffraction studies (Coates et al.,
2001, 2008).
The topology of the substrate-binding cleft can be described
using the notation of Schechter & Berger (1967). The binding
cleft can be divided into subsites (S), each occupied by one
residue (P) of the substrate. These subsites and corresponding
substrate residues are numbered counting away from the
active site towards the N-terminus (S1 and P1, S2 and P2 etc.)
and the C-terminus (S10 and P10, S20 and P20 etc.) of the
substrate (e.g. residue P20 binds in subsite S20). The peptide
bond between residues P1 and P10 that is hydrolysed by the
enzyme is referred to as the scissile bond. The substrate
specificity of the enzyme depends on the properties (shape,
charge etc.) of the subsites, which are therefore often referred
to as ‘specificity pockets’. The aspartic peptidases are char-
acterized by their large hydrophobic S1 and S10 pockets and
have a preference for substrates with large hydrophobic resi-
dues at P1 and P10 (Kay & Dunn, 1992). Part of the binding
cleft is made up by a -hairpin flap comprised of residues
69–79 (chymosin numbering), which was found to display a
very large mobility in bovine chymosin. In the structure with
bound inhibitor (Groves et al., 1998) the flap was in the same
conformation as in other peptidases, e.g. porcine pepsin
(Cooper et al., 1990; Sielecki et al., 1990). However, in the
native structure the flap adopted a different position with the
side chain of Tyr77 blocking access to the substrate-binding
cleft (Gilliland et al., 1990; Newman et al., 1991). It has been
suggested that this self-inhibitory behaviour of bovine
chymosin contributes to its increased specificity (Andreeva et
al., 1992), and kinetic studies have indicated that a His-Pro
cluster in bovine -casein (all -casein residues are written in
italics) acts as an allosteric regulator that converts chymosin
into its active form (Gustchina et al., 1996).
The clotting of milk is initiated by removing the hydrophilic
and predominantly negatively charged C-terminus (Supple-
mentary Fig. S41) of -casein, the milk protein that forms part
of the outer layer of the casein micelles. More specifically, the
C-terminus is removed by hydrolysing the Phe105-Met106
bond of -casein or nearby bonds (Fox & McSweeney, 1998).
This causes exposure of the hydrophobic core of the casein
micelles, thereby leading to aggregation, gel formation and
phase separation of the milk into curds and whey.
The dairy industry characterizes rennet enzymes using two
properties. The first is the milk-clotting activity (C) expressed
in International Milk-Clotting Units (IMCU). It is determined
by a standard method (International Dairy Federation, 2007)
that describes the ability to aggregate milk by cleaving the
Phe105-Met106 bond or nearby bonds of -casein. The second
property is the general proteolytic activity (P), which is the
ability to cleave any bond in casein (Kappeler et al., 2006). The
ratio between the two properties, the C/P ratio, captures the
essential quality of a milk-clotting enzyme. The higher the
value the better the rennet, and in this regard chymosin is
superior to all other known rennet enzymes (Foltmann, 1992).
The C/P ratio of bovine chymosin towards bovine milk is
higher than those of the chymosins from lamb, pig, cat and seal
(Foltmann, 1970). However, camel chymosin produced in
Aspergillus niger shows a sevenfold higher C/P ratio than
bovine chymosin (70% higher clotting activity and only 25%
of the general proteolytic activity; Kappeler et al., 2006).
Bovine and camel chymosin both consist of 323 residues and
display high sequence identity (85%; Supplementary Fig. S4).
In contrast, bovine chymosin displays a very low milk-clotting
activity towards camel milk (Farah & Bachmann, 1987;
Kappeler et al., 2006).
The commercial bovine and camel chymosin products used
in this investigation originate from production in A. niger
(Harboe, 1992; Kappeler et al., 2006). Natural bovine
chymosin is found in two isoforms, A and B, which differ at
residue 244, which is an Asp in the A form and a Gly in the B
form (Foltmann, 1966). It is the B form that is used in the
investigations described in this paper, as it is commercially
available in large quantities at high purity; it is referred to as
‘bovine chymosin’. A. niger is known to glycosylate proteins at
the N2 atom of an Asn found in the sequence Asn-X-Thr/Ser,
research papers
902 Jensen et al.  Chymosin Acta Cryst. (2013). D69, 901–913
1 Supplementary material has been deposited in the IUCr electronic archive
(Reference: WD5199). Services for accessing this material are described at the
back of the journal.
where X cannot be Glu or Pro. The sites with Thr are found
to have a higher degree of glycosylation than those with Ser
(Harboe, 1998). These will be referred to as ‘more favoured’
(Thr) and ‘less favoured’ (Ser) sites. Bovine chymosin contains
two less favoured glycosylation sites at Asn252 and Asn291
(Supplementary Fig. S4). Approximately 10% of the bovine
chymosin produced by fermentation is glycosylated (unpub-
lished data from Chr. Hansen A/S), but the distribution
between the sites is unknown. Camel chymosin possesses two
glycosylation sites: a favoured site at Asn100 and a less
favoured site at Asn291. The extent of glycosylation ofA. niger
fermented camel chymosin has not previously been investi-
gated.
The primary aim of the research presented here is to
provide a structural understanding of why camel chymosin
possesses a higher milk-clotting activity towards bovine milk
than bovine chymosin. We report the separation and char-
acterization of the variants of camel chymosin obtained from
expression in A. niger and the crystal structure of one of the
variants of camel chymosin to 1.6 A˚ resolution. The structure
of bovine chymosin was determined more than 20 years ago
(Gilliland et al., 1990; Newman et al., 1991; Strop et al., 1990),
and as no structure factors were available for these structures
the structure of bovine chymosin has been redetermined
benefitting from the improved methods of macromolecular
crystallography. Based on X-ray synchrotron-radiation data,
the structure of bovine chymosin has been redetermined to
1.8 A˚ resolution. These structures form the basis for detailed
structural comparison that has identified structural differences
that can explain the better performance of camel chymosin in
terms of substrate recognition and action on -casein.
2. Methods
2.1. Reagents and proteins
Buffers were prepared using analytical grade chemicals
followed by sterile filtration. The buffers used for fast protein
liquid chromatography (FPLC) were degassed by ultra-
sonication at 42 kHz for 10 min. Transfers to new buffers were
made using Econo-Pac 10DG columns. The bovine and camel
chymosins were the commercial products Chy-MAX and Chy-
MAX M, respectively, provided by Chr. Hansen A/S.
Bovine chymosin can be obtained by expression of the
vector pGAMpR (Ward et al., 1990) in the strain A. niger
var. awamori GC1HF1-3;dgr246. This strain has been heavily
modified for heterologous protein expression, for example by
deletion of the gene coding for aspergillopepsin A in order to
limit protein degradation (Berka et al., 1991). Camel chymosin
can be obtained by expression in the same strain of a modified
vector, pGAMpR-C, that contains the camel chymosin gene
(Kappeler et al., 2006).
2.2. Separation of variants
The variants of bovine and camel chymosin were separated
by hydrophobic interaction chromatography using an
A¨KTApurifier 900 FPLC system. The commercial products
were suspended in 12%(w/v) NaCl. The separation of camel
chymosin variants was carried out by adding sodium sulfate
to the commercial product to a final concentration of 0.5M.
The binding buffer was 12%(w/v) NaCl, 0.5M sodium sulfate,
50 mM NaH2PO4 pH 6.5 and the elution buffer was 50 mM
NaH2PO4 pH 6.5. Camel chymosin variants were separated on
a Phenyl Superose column from Pharmacia. The separated
camel chymosin variants 2 and 3 contained traces of the
neighbouring variants (Fig. 1); hence, they were separated
once more following the same procedure but adding salts to
the sample to match the binding buffer. The variants were
transferred to 50 mM bis-tris buffer pH 6.0 containing
0.05%(w/v) sodium azide.
Bovine chymosin variants were separated following the
same procedure but using a concentration of 0.4M sodium
sulfate in the sample and binding buffers. The variants were
transferred to 50 mM NaH2PO4 pH 6.0 containing 0.05%(w/v)
sodium azide.
2.3. Deglycosylation
Bovine and camel chymosin (0.9 and 2.1 mg ml1, respec-
tively) were deglycosylated with endoglycosidase H (Sigma,
catalogue No. A0810). 25 milliunits was added per millilitre of
sample, which was incubated at 278 K for 4 d. Separation of
the deglycosylated samples followed the same procedure as
described above for the commercial products.
2.4. Mass spectrometry
The protein mass was measured using a Voyager Elite
MALDI TOF mass spectrometer (Applied Biosystems Inc.,
Framingham,Massachusetts, USA) operated in linear positive-
ion mode. The separated variants were desalted and
concentrated on 50R1 microcolumns (Gobom et al., 1999),
subsequently eluted and deposited on a stainless-steel
MALDI target with a matrix solution consisting of 20 mg ml1
sinapinic acid in 70% acetonitrile and 0.1% trifluoroacetic
acid. The target spots were pretreated with 0.5 ml sinapinic
acid in acetone (20 mg ml1). Samples were analysed in the
mass range 3–50 kDa. The data were baseline-corrected and
noise-filtered.
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Figure 1
Representative chromatograms showing the FPLC separation of
commercial camel chymosin using a salt gradient on a hydrophobic
column. The black chromatogram shows the separated variant products
numbered 1–6. The green chromatogram shows the separation of the
product pretreated with endoglycosidase H.
2.5. N-terminal sequencing
An ABI 494 protein sequencer equipped with an ABI 140A
microbore HPLC system (Applied Biosystems, Foster City,
California, USA) was employed for N-terminal sequencing
using sequencing-grade chemicals from Fluka.
2.6. Determination of glycosylation types and sites
Chymosin samples were digested with trypsin (Promega;
modified, sequencing grade) and Asp-N (Calbiochem; exci-
sion grade) (Højrup, 2009). 2 mg enzyme was added per 100 mg
protein. After lyophilization approximately 2 mg of the sample
was redissolved in 10 ml 80% acetonitrile and 2% formic acid
and purified on a Polyhydroxyethyl A (PolyLC) or a hydro-
philic interaction liquid chromatography (HILIC) micro-
column (Gobom et al., 1999; Thaysen-Andersen et al., 2007).
The samples were eluted onto a target plate and mixed with
0.5 ml matrix solution as described by Thaysen-Andersen et al.
(2007). Mass spectra (full scan and daughter-ion scans) were
recorded using a 4800 Plus MALDI TOF/TOF (AB Sciex)
mass spectrometer operated in reflector positive-ion mode.
The acceleration voltage was 20 kV. Depending on the sample
analysed, the laser intensity and the number of laser shots
were varied to optimize the spectral appearance. The mass
range was set to 700–8000 Da. For all MS/MS data air was used
as the collision gas.
2.7. Assay for enzymatic activity
The milk-clotting activity of the enzymes was determined
using the standard milk-clotting assay (International Dairy
Federation, 2007), which gives the activity in International
Milk-Clotting Units (IMCU) by measuring the time required
to achieve clotting of standardized skimmed milk compared
with a standard enzyme sample. Using this method, the milk-
clotting activities of the bovine and camel chymosin variants
and the camel chymosin crystals resuspended in 50 mM bis-tris
buffer pH 6.0 were determined.
2.8. Thermal stability measurements
The melting temperatures (Tm) were determined by
differential scanning calorimetry (DSC) using a VP-DSC
microcalorimeter (MicroCal). As the pH of bis-tris buffer
varies significantly with temperature, all samples were
transferred into 50 mM NaH2PO4 buffer pH 6.0 containing
0.05%(w/v) sodium azide. The samples were degassed for
5 min prior to measurements.
The samples were scanned at a rate of 1 K min1. An initial
scan of the two commercial products was made in the range
293–383 K. A single transition point was found at about 333 K.
This information was used to set the temperature range to
313–343 K for the separated variants with concentrations of
2.8–20.0 mM. At higher concentrations an exothermic contri-
bution interfered with the signal for camel chymosin. At
protein concentrations below 20 mM there was no variation of
the Tm with the protein concentration. Both bovine and camel
chymosin denatured irreversibly upon heating (Supplemen-
tary Fig. S2).
Data processing was performed with the OriginLab 7
software. Buffer–buffer scans were subtracted from the
protein–buffer scans followed by a baseline subtraction using
a cubic function and normalized with the protein concentra-
tion to give a profile of excess molar specific heat (CP,m) as a
function of temperature. The melting temperature, Tm, was
defined as the temperature at maximum CP,m.
2.9. Crystallization experiments
Crystallization trials were performed on the most abundant
variants of camel chymosin: variants 2 and 3. The crystal-
lization experiments were carried out by the vapour-diffusion
method at room temperature. Drops composed of 2 ml protein
solution [25 mg ml1 in 50 mM bis-tris buffer pH 6.0,
0.05%(w/v) sodium azide] and 2 ml precipitant were equili-
brated against a 1 ml reservoir of precipitant. After 1 d,
variant 2 of camel chymosin formed crystals at a protein
concentration of 25 mg ml1 using a reservoir consisting of
2M ammonium sulfate, 100 mM bis-tris buffer in the pH range
5.1–6.5 (the protein precipitated at pH 4.5). A few large
crystals appeared at pH 5.1; they increased in number while
decreasing in size as the pH increased. A crystal obtained at
pH 5.5 with dimensions of 150  100  100 mm was used for
initial data collection at 100 K. The crystal was cryoprotected
in reservoir solution with 0.5M lithium sulfate (Rubinson
et al., 2000). Another data set with improved resolution was
collected from a crystal grown under the same conditions but
using a protein concentration of 30 mg ml1.
Bovine chymosin was crystallized under conditions similar
to those described previously (Gilliland et al., 1990; Strop et al.,
1990; Newman et al., 1991). The composition of the reservoir
was 100 mM NaH2PO4 pH 5.5, 1.5M NaCl. Each drop was
composed of 2 ml reservoir solution and 2 ml bovine chymosin
sample at 30 mg ml1 (the commercial product transferred to
50 mM NaH2PO4 pH 6.0). The commercial product contained
only one dominant variant; hence, no further separation was
deemed necessary. Crystals of diffraction quality appeared
after 2 d by seeding with bovine chymosin crystals provided by
Chr. Hansen A/S. Crystals of dimensions 100  30  30 mm
were cryoprotected in reservoir solution with 2.5M LiCl
(Rubinson et al., 2000).
2.10. Data collection and structure refinement
Data were collected for both enzymes on the Cassiopeia
beamline station I911-2 at MAX-lab, Lund University
(Mammen et al., 2002, 2004) equipped with a MAR 165 CCD
detector at a crystal-to-detector distance of 100 mm. Data
reduction and determination of the space group and unit-cell
parameters were carried out with the XDS software package
(Kabsch, 2010). The crystals of bovine chymosin belonged to
space group I222, as reported previously, but diffracted to
a higher resolution (1.8 A˚) than the previously published
structures (Gilliland et al., 1990; Strop et al., 1990; Newman et
al., 1991). The crystals of camel chymosin belonged to space
research papers
904 Jensen et al.  Chymosin Acta Cryst. (2013). D69, 901–913
group P212121. Statistics are summarized in Table 1. The CCP4
suite (Winn et al., 2011) was used to convert the data into a file
format for molecular replacement and to flag 5% of the
reflections for calculation of the free R factor.
The PHENIX software suite (Adams et al., 2010) was used
to solve the structure of camel chymosin by the molecular-
replacement method using a trimmed version of bovine
chymosin (PDB entry 1cms; Gilliland et al., 1990; loops and
the N-terminus removed) as a search model. The PHENIX
software suite (Adams et al., 2010) was used for refinement
and the molecular-graphics application Coot (Emsley et al.,
2010) was employed for manual building of the model. It was
not possible to trace the first ten residues of the N-terminus. In
order to investigate this, another data set was collected from a
crystal grown from a freshly prepared sample. Although the
resolution was improved from 1.9 to 1.6 A˚, the N-terminus
was also absent in the electron density based on these data.
N-terminal analysis and mass spectrometry showed that the
polypeptide chain lacked the first three residues and had
the same degree of glycosylation as the original sample. An
N-acetylglucosamine (NAG), the first residue in the sugar
chain, could be modelled at Asn100. Water molecules were
fitted manually in both structures. Higher residual density at
the surface of the protein was modelled as ten sulfate ions that
could be refined with B factors similar to those of the adjacent
protein residues. Residual density in the active site was
modelled as a glycerol molecule. The side chain of Cys283 was
fitted in two different conformations: one corresponding to
the disulfide bridge to Cys250 and the other with a disrupted
bridge presumably caused by radiation damage during data
collection. Dual conformations were also introduced for the
side chains of Val32, Ser226 and Val317.
The same refinement procedure was used for the structure
of bovine chymosin. Eight of the peaks in the residual density
that displayed high density were introduced as chloride ions,
the B factors of which refined to values that matched those of
the protein.
The geometry and local environment of the models were
validated with the program WHAT IF (Vriend, 1990). The
electron densities of the outliers in the Ramachandran plot
are well defined, apart from the loop residues Gln162 in both
structures, Gln280 in bovine chymosin and Ser164 in camel
chymosin.
Table 2 contains a summary of the refinement and model
statistics.
2.11. Electrostatic calculations
The pI and surface charges of bovine and camel chymosin
were calculated with the Adaptive Poisson-Boltzmann Solver
(APBS) software (Baker et al., 2001), the PDB2PQR software
(Dolinsky et al., 2004, 2007) and PROPKA 1.0 (Li et al., 2005).
The structural models used were those obtained from the
refinement of the two structures, including only structural
water molecules and encompassing the full sequence for
bovine chymosin and residues 11–323 for camel chymosin. The
calculations were carried out for the protein under conditions
commonly used in the manufacture of cheese: pH 6.65 with
a concentration of free calcium ions of approximately 3 mM
and a total ionic strength of approximately 80 mM (Fox &
McSweeney, 1998) represented by 74 mM NaCl.
3. Results
3.1. Separation and characterization of variants
The separation showed that the camel chymosin produced
byA. niger fermentation contained six different variants of the
camel enzyme, as shown in Fig. 1. They will be referred to as
research papers
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Table 1
Data-collection and processing statistics.
Values in parentheses are for the highest resolution shell.
Bovine chymosin Camel chymosin
Space group I222 P212121
Unit-cell parameters (A˚)
a 71.6 53.3
b 79.2 66.1
c 113.2 133.7
Mosaicity () 0.220 0.101
Wavelength (A˚) 1.04 1.04
Resolution range (A˚) 30.0–1.80 (1.90–1.80) 30.0–1.60 (1.70–1.60)
Total reflections 243754 539439
Unique reflections 30113 62765
Multiplicity 8.1 (8.0) 8.6 (8.6)
Rmerge† 0.079 (0.498) 0.036 (0.321)
Completeness (%) 99.7 (99.0) 99.2 (97.8)
hI/(I)i 19 (5) 31 (6)
† Rmerge =
P
hkl
P
i jIiðhklÞ  hIðhklÞij=
P
hkl
P
i IiðhklÞ.
Table 2
Structure-refinement and validation statistics.
Bovine chymosin Camel chymosin
Resolution range (A˚) 26.6–1.80 24.8–1.60
Rfree† 0.215 0.208
Rwork‡ 0.177 0.186
Reflections (total) 30027 62748
Reflections (Rfree test set) 1520 3182
Solvent content (%) 46 58
Molecules in the asymmetric unit 1 1
No. of atoms 2890 2968
No. of amino-acid residues 323 312
No. of carbohydrates 0 1
No. of anions 8 10
No. of solvent molecules 370 442
Average B factor (A˚2)
Overall 23.4 24.4
Amino acids 22.2 21.6
Anions 26.1 52.0
Carbohydrates — 48.1
Ligand — 41.4
Water molecules 31.7 35.8
R.m.s.d. from ideal
Bond lengths (A˚) 0.008 0.007
Bond angles () 1.032 1.061
Ramachandran outliers Leu12, Ser94,
Gln162, Gln189,
Gln280
Tyr134, Gln162,
Ser164, Gln189
† Rwork =
P
hkl

jFobsj  jFcalcj

=
P
hkl jFobsj, where Fcalc is the structure factor calculated
from the model and Fobs is the structure factor of the observed reflections used for model
building. ‡ Rfree =
P
hkl

jFobsj  jFcalcj

=
P
hkl jFobsj, where Fcalc is the structure factor
calculated from the model and Fobs is the structure factor of the observed reflections
retained from model building (the Rfree test set).
camel chymosin variants 1–6 based on their elution order (as
determined by their hydrophobicity). The elution profile of
the endoglycosidase-treated sample differs distinctly from
the profile of the untreated sample, showing that the variants
differ in their glycosylation patterns (Fig. 1). The six variants
also displayed different behaviour on an isoelectric focusing
gel (results not shown), supporting their distinct differences.
Fig. 1 shows that in commercial camel chymosin variants 2
and 3 form the major components, while variants 1 and 6 are
only present in minor amounts. A similar chromatographic
separation of commercial bovine chymosin (Supplementary
Fig. S1) showed that it is comprised of two variants. The more
abundant variant is unglycosylated, while the other variant is
glycosylated at Asn291.
N-terminal analysis, mass spectrometry, differential scan-
ning calorimetry, identification of glycosylation sites and the
milk-clotting activity assay were used to characterize the
different variants and the commercial camel and bovine
chymosin products. The results of these investigations are
summarized in Table 3.
The sequence of camel chymosin suggested two possible
N-glycosylation sites: a more favoured one at Asn100 and a
less favoured one at Asn291; according to this, the six variants
can be classified into three groups according to their degree of
glycosylation. Based on the mass-spectrometric (MS) char-
acterization, variants 1 and 2 are found to be doubly
glycosylated, variants 3 and 4 to be singly glycosylated and
variants 5 and 6 to be unglycosylated. MS/MS data (not
shown) confirmed glycosylation at Asn100 of variant 2. It was
identified to be high mannose, with a core structure containing
at least 13 mannose residues. The glycosylation site at Asn291
had similar characteristics but contained at least 23 mannose
residues. The six variants were also characterized through
N-terminal sequencing. Apart from variant 1, which lacks
the first three residues, the other variants had an intact
N-terminus. These results are supported by traditional and
off-line MS/MS analysis (data not shown). Based on these
experiments, we conclude that variant 2 possesses the full
sequence and is doubly glycosylated at Asn100 and Asn291.
The crystals obtained by crystal-
lization of variant 2 contained a
protein lacking the first three
residues of the N-terminus. It is
likely that this has been caused
by autocatalysis, as variant 2 had
been subjected to an additional
separation to remove traces of
variant 1 and the expression
system did not contain additional
peptidases. The double glycosyl-
ation of the protein in the crystals
was confirmed by MS (Supple-
mentary Fig. S11). Variants 3 and
4 are glycosylated at Asn100 and
variants 5 and 6 are unglycosyl-
ated. The difference between
variants 3 and 4 can be explained
by differences in the glycosylation at Asn100. However, it was
not possible to identify the cause of the differences in the
elution profiles and the masses of the two unglycosylated
variants 5 and 6. The degree of glycosylation appears to have
an impact on the thermal stability of the variants. The singly
glycosylated variant possesses the highest melting point
(334.4 K). Both the doubly glycosylated and the unglycosy-
lated variants of camel chymosin have lower melting points;
however, they are all significantly higher than the Tm that was
measured for bovine chymosin.
The commercial camel chymosin product has almost twice
the milk-clotting activity when compared with the bovine
chymosin product. In addition to this, the six variants of camel
chymosin show significant variation in their milk-clotting
activities (Table 3). The single and unglycosylated variants (3–
6) are those with the highest activity. It is noteworthy that it is
the doubly glycosylated variant 1 of camel chymosin that lacks
the first three residues which displays the lowest activity.
3.2. Structures of bovine and camel chymosin
The crystal structures of bovine and camel chymosin are
illustrated in Fig. 2. In this and all subsequent illustrations,
bovine chymosin is shown in light orange and camel chymosin
in pale cyan. The rigid cores of the camel and bovine chymosin
structures superimpose well, with a root-mean-square devia-
tion (r.m.s.d.) of 0.63 A˚ (1457 atoms). The structure of bovine
chymosin does not differ from the three structures determined
previously (Gilliland et al., 1990; Strop et al., 1990; Newman et
al., 1991) and can be superimposed with the earlier structures
with an r.m.s.d. of 0.39  0.02 A˚ (comparing 1733 atoms on
average). The structural models of the two enzymes contain a
significant number of anions close to the positively charged
residues at the surface. This is likely to be an effect of the
relatively high concentration of salts in the crystallization
medium (1.5M NaCl for the bovine enzyme and 2M ammo-
nium sulfate for the camel enzyme). The electron density of
the associated cations was comparable to the density of water
molecules; even if one considers the differences in the inter-
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Table 3
Properties of the separated variants of camel chymosin.
For comparison, commercial bovine and camel chymosin have milk-clotting activities of 223 and 462 IMCU mg1,
respectively (data from Chr. Hansen A/S). Their melting points were determined to be 330.8 and 333.8 K,
respectively.
Variant 1 2 3 4 5 6
Sequence† 4–323 1–323 1–323 1–323 1–323 1–323
Mass spectrometry
Peak‡ (kDa) 40.2 40.3 37.7 37.7 35.6 35.8
Range§ (kDa) 39.0–42.0
(49.0–51.5)
39.5–42.0 36.5–38.5 36.5–39.0
(35.0–36.0)
Glycosylation Asn100, Asn291 Asn100, Asn291 Asn100 Asn100
Activity (IMCU mg1) 123  2 289  1 396  1 467  1 474  5 426  8
Tm} (K) 333.0 333.6 334.4 334.4 332.5 332.2
† The full sequence of mature bovine and camel chymosin consists of residues 1–323. ‡ The average mass of the peaks in the
spectra. § For the heterogenously glycosylated camel chymosin variants 1–4 the mass range is given as the full width at half
maximum (the spectra have been deposited as Supplementary Material). Values in parentheses represent minor peaks in the
spectra. } The melting point, Tm, is defined as the temperature at maximum molar specific heat, CP,m.
actions of a cation and a water molecule it was not possible to
distinguish any bound cations in the structures of camel and
bovine chymosin.
The doubly glycosylated variant 2 was used for the crys-
tallization of camel chymosin. The experimentally verified
glycosylation sites of the two structures are marked in yellow
in Fig. 2. Asn100 is located in a -strand and Asn291 is located
in a loop. The structural comparison of bovine and camel
chymosin revealed no conformational differences between the
two structures in the parts of the structure that carry the two
glycosylation sites.
The structural model of camel chymosin contains an NAG
residue covalently bound to Asn100 and this does not appear
to influence the atomic displacement parameters, which are
similar to the values for bovine chymosin. The loop carrying
the other glycosylation site at Asn291 is in a flexible part of the
molecule as judged from the values of the atomic displacement
parameters of the backbone atoms, which are around 40 A˚2 in
both structures, which is significantly above the average value
for the protein (Table 2). The higher mobility of the loop
containing Asn291 could explain why it was not possible to
identify any carbohydrate bound to Asn291 in the electron
density, even though mass spectrometry of the crystals had
shown that camel chymosin was glycosylated at both sites. The
structural similarity between unglycosylated bovine chymosin
and doubly glycosylated camel chymosin leads us to conclude
that the post-translational modifications introducing
glycosylation do not influence the overall fold of the poly-
peptide chain of chymosin.
One of the most significant differences between the two
structures is in their N-termini (Fig. 3). In both the present
structure of bovine chymosin and those determined by Gilli-
land et al. (1990), Strop et al. (1990), Newman et al. (1991) and
Groves et al. (1998), the N-terminus is visible and forms one
of the strands in an antiparallel -sheet as in other aspartic
peptidases such as porcine pepsin (Cooper et al., 1990; Sielecki
et al., 1990). Residues 5 and 6 are Ser and Val in the bovine
enzyme and are Arg and Glu in the camel enzyme. In bovine
chymosin the -strand is formed by residues 4–6, with Ala4
and Val6 forming hydrogen bonds to Leu168 and Leu166,
respectively. Replacement of Val6 by Glu would be energeti-
cally very unfavourable in the hydrophobic environment of
the -sheet. The differences in the N-termini of the two
structures are illustrated in Fig. 3, in which the residues up to
residue 16 are coloured magenta. The first ten residues are
not visible in camel chymosin. Despite the fact that the two
enzymes have an identical sequence from residues 11 to 16
they adopt completely different conformations, as shown in
Fig. 3. The engagement of residues 4–6 in the -sheet in bovine
chymosin keeps the N-terminal loop in a conformation in
which it forms part of the binding cleft; in camel chymosin the
same residues point towards the active site. The location of
Tyr11 (Fig. 3) illustrates well the significant differences in
conformation between camel and bovine chymosin. In camel
chymosin it blocks a major part of the binding cleft and must
undergo a conformational change upon binding of substrate. It
should be emphasized that the solvent region close to Tyr11 in
camel chymosin is sufficiently spacious to be able to accom-
modate residues 4–10 and does not provide any steric
hindrance to conformational changes of residues 10–16. The
lack of hydrogen-bond partners for the -strand formed by
residues Leu166–Leu168 is compensated in camel chymosin
by a slight displacement of the loop formed by residues 93–96,
which enables the side chain of Ser94 to form a hydrogen bond
to the carbonyl group of Leu166, thus connecting the -strand
to the loop 93–96.
To elucidate the state of the N-terminus, freshly grown
crystals of camel chymosin were used for data collection,
research papers
Acta Cryst. (2013). D69, 901–913 Jensen et al.  Chymosin 907
Figure 2
Structures of bovine chymosin (a) and camel chymosin variant 2 (b). The active-site residues and activated water molecule are shown in red and the
N-terminal residues up to and including Tyr16 are shown in magenta. The experimentally verified glycosylation sites and N-acetylglucosamine are shown
in yellow and the chloride ions are shown as green spheres; stick models are used for sulfate ions and glycerol.
resulting in higher resolution. N-terminal analysis, MS and
activity measurements on resuspended crystals revealed that
the protein lacked the first three residues and had decreased
activity, like variant 1.
3.3. Surface charge
The surface charges of the two enzymes were calculated at
pH 6.65, which is the physiological pH of milk (Fox &
McSweeney, 1998). The results are displayed in Fig. 4. The
overall charge of bovine chymosin is 15 ec, which is lower
than the overall charge for camel chymosin,9 ec, as expected
from their pI values: 4.8 for bovine chymosin and 5.4 for
camel chymosin (unpublished results from Chr. Hansen A/S).
However, the real difference is larger considering that the
model of the camel enzyme lacked the first ten residues, which
carry a net charge of +1 compared with 1 for the same
residues in bovine chymosin (Supplementary Fig. S4).
Previous studies of bovine chymosin have identified a posi-
tively charged patch on the N-terminal domain and a nega-
tively charged patch on the C-terminal domain adjacent to
the substrate-binding cleft; these patches were suggested to
influence the interaction with -
casein (Gilliland et al., 1990;
Newman et al., 1991). The posi-
tively charged patch (roughly
corresponding to the first patch in
Fig. 4) is larger in camel chymosin
owing to the replacement of a
Gln by a His at position 56. The
negatively charged patch is less
negative in camel chymosin
owing to the replacement of
Asp249 and Asp251 by Asn249
and Gly251 (part of the second
patch). In addition, camel
chymosin possesses a small posi-
tive patch on the C-terminal
domain comprised of residues
Arg242, Arg254 and Lys278 (part
of the second patch); the corre-
sponding residues in the bovine
enzyme are hydrophilic but
neutral. The replacement of
Gln150 and Leu316 in bovine
chymosin by Arg150 and Arg316
in camel chymosin introduces an
additional third positive patch on
the surface of camel chymosin
that contributes to the significant
differences in surface charge
between camel and bovine
chymosin.
4. Discussion
The different degrees of
glycosylation observed for the
variants of camel chymosin exert
only a very small effect on the
thermal stability, as shown in
Table 3. The singly glycosylated
variants have slightly higher
melting points than the doubly
and unglycosylated variants. This
suggests that glycosylation at
Asn100, the more favoured site,
with bound NAG is an integral
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Figure 3
Illustration of the differences in the conformation of the N-terminus of bovine chymosin (a) and camel
chymosin (b) in relation to the central -sheet. The view is from the N-terminal domain towards the
C-terminal domain. The active-site residues and the activated water molecule are shown in red and the
N-terminal residues up to and including Tyr16 are shown in magenta. The side chain of Ser94 is shown in
red/blue and the hydrogen bond formed to the -sheet in camel chymosin is marked in yellow. The chloride
ion in bovine chymosin is illustrated as a green sphere and the glycerol (Gol1334) in camel chymosin
is shown in stick representation. (c) Enlargement of the environment of Val6 (within 5 A˚) in bovine
chymosin, where Phe33, Val93, Leu166, Leu168 and solvent interact with the side chain. The sequence and
charge of residues 1–16 in camel and bovine chymosin at pH 6.65 are shown in the box, noting that camel
chymosin lacks residues 1–3. (d) The electron density in the active site of camel chymosin corresponding to
the two active-site Asp residues, the activated water molecule, Tyr11 and glycerol (Gol1334). The electron
density is traced at the 1.0 level.
part of a structure with higher molecular mass. Bovine
chymosin has a slightly lower (2 K) melting point than the
camel enzyme. Even taking the lack of glycosylation into
account this is a surprising result, as the disordered N-
terminus of camel chymosin could be interpreted as a partial
unfolding of the structure, as suggested from studies of other
aspartic peptidases (Lin et al., 2000; Tanaka & Yada, 2001).
The disordered N-terminus leads to the net loss of one
hydrogen bond, which could suggest that entropic differences
contribute to the slightly higher melting point of camel
chymosin relative to bovine chymosin.
The casein micelles in milk are the natural substrate of
chymosin. The complex composition and structure of this very
large substrate make it particularly challenging to relate
differences in the catalytic activity measured as the milk-
clotting activity to the structural differences between camel
and bovine chymosin. Among the factors that could be
expected to affect the enzymatic action of chymosin on casein
micelles are the mutual attraction and positioning of the
overall negatively charged chymosin in a favourable position
that will allow binding to the overall negatively charged
C-terminal part of -casein in the active site and the subse-
quent cleavage of the substrate at the scissile bond Phe105-
Met106. These points will be considered in the analysis of the
structural differences between camel and bovine chymosin.
4.1. Impact of glycosylation
The additional glycosylation site at Asn100 in camel
chymosin accounts for the larger number of variants found.
The characterization of the variants, summarized in Table 3,
suggests a correlation between the milk-clotting activity and
the location of the glycosylation site relative to the binding
site. The glycosylation site at Asn291 is located close to the
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Figure 4
Electrostatic surface plots of bovine (a) and camel (b) chymosin oriented with the C-terminal domain to the left and the N-terminal domain to the right,
looking into the binding cleft (top) and rotated 180 around the horizontal direction (bottom). The scales indicate the charge in kBT/ec. The box shows
the sequence of the charged patches; their corresponding positions on the surface are marked in (a) and (b).
entrance to the substrate-binding cleft (Fig. 2) and could
impair substrate binding and thus explain the significantly
lower activities of the doubly glycosylated camel chymosin
variants 1 and 2, which are approximately 25 and 60%,
respectively, of that of variant 5 (see Table 3). The other
glycosylation site at Asn100 is located far away from the
binding cleft (Fig. 2), and variants 3 and 4, which are
glycosylated only at this site, have the same milk-clotting
activity as the unglycosylated variant 5. The drop in the
measured activity of variant 3 was caused by the presence of a
small amount of variant 2, as seen in Fig. 1 and Supplementary
Figs. S6 and S7.
4.2. Surface charge
Bovine -casein is a relatively small milk protein comprising
169 residues; it has been shown that residues 97–112 play a
role in the interaction with chymosin and that the last part
of the C-terminus is disordered, which is consistent with the
extensive O-glycosylation of the C-terminus (Fox &
McSweeney, 1998). Several residues in the sequence of
-casein close to the Phe105-Met106 bond are positively
charged (Supplementary Fig. S4) under cheese-making
conditions (pH 6.65) and fit well with the overall negative
charge of bovine and camel chymosin. On the other hand, the
remaining part of the C-terminus of -casein is negatively
charged owing to the presence of several Asp and Glu resi-
dues (Fox & McSweeney, 1998) and might therefore be
expected to be repelled by the negatively charged chymosin,
an effect that will be less pronounced for camel chymosin since
it possesses a smaller negative charge. However, as can be seen
from the electrostatic surface plots in Fig. 4, both bovine and
camel chymosin contain positively charged areas (the first and
second patches, the latter of which is only present in camel
chymosin). These are located just outside the substrate-
binding cleft, which may aid in orienting the enzyme and its
subsequent association with the negatively charged C-terminal
part of -casein. The chloride ions in bovine chymosin and the
sulfate ions in camel chymosin are located adjacent to these
patches, demonstrating the impact of the positively charged
patches of the structures. The negatively charged C-terminus
of -casein will be repelled by the negative patches and
attracted by the positive patches. These interactions can
facilitate the binding of the C-terminus in the active site. Both
the electrostatic surface maps in Fig. 4 and the locations of
the anions in the structures illustrated in Fig. 2 revealed the
existence of an additional positive patch on the surface of
camel chymosin (the third patch), which could be of impor-
tance for the attraction of the negatively charged C-terminus
of -casein. This is in agreement with a previous suggestion
that the positively charged residues in the stretch 48–62 of
bovine chymosin could aid in stabilization of the enzyme–
substrate complex (Gilliland et al., 1990). The additional
positive charges of camel chymosin are therefore likely to
contribute to its improved milk-clotting properties relative to
bovine chymosin.
4.3. N-terminus
The most significant structural difference between camel
chymosin and bovine chymosin is observed in their secondary-
structural elements. A prominent secondary structure in
bovine chymosin is the central six-stranded antiparallel
-sheet at the ‘bottom’ of the active site, which links and
stabilizes the relative orientation of the two domains in the
structure. The N-terminus of bovine chymosin forms one of
the strands in this sheet. The disordered N-terminus of camel
chymosin implies that this structure lacks one of the strands,
which leads to a breakdown of the pseudo-twofold symmetry
that relates the two domains of the chymosin structure
(Newman et al., 1991). It has been shown that the two domains
of chymosin move relative to each other upon inhibitor
binding (Sˇali et al., 1992; Groves et al., 1998), and the relative
domain movement within camel chymosin must be influenced
by the breakdown of symmetry.
A comparison of the sequences of camel chymosin and
bovine chymosin (Supplementary Fig. S4) shows why it would
not be possible for the N-terminus of the camel enzyme to
adopt the same conformation as the N-terminus of bovine
chymosin. The presence of the large charged Arg5 and Glu6
residues (Ser5 and Val6 in bovine chymosin) adjacent to each
other precludes the participation of the N-terminus in the
-sheet, as one of them must be buried in the hydrophobic
core of the protein. In bovine chymosin the -strand is formed
by residues 4–6, with Ala4 and Val6 hydrogen bonded to
Leu168 and Leu166, respectively. The replacement of Val6 by
Glu would be energetically unfavourable in the hydrophobic
environment.
Arg5 and Glu6 in camel chymosin make it unfavourable
for the N-terminus to adopt a well defined conformation
embedded in the structure. This could explain why it points
into the solvent, giving rise to a less compact crystal packing of
camel chymosin compared with the bovine enzyme. Among
the other significant differences between the sequences of the
N-termini of camel and bovine chymosin is the overall positive
charge of the N-terminus of the camel enzyme, which is partly
owing to the substitution of a Glu in position 2 of bovine
chymosin by a Lys in camel chymosin. The decrease in activity
associated with the lack of the first three residues in the
sequence shows the significance of the positively charged and
disordered N-terminus. One could even envision that the
positively charged disordered N-terminus of camel chymosin
acts as a bait for the negatively charged disordered C-terminus
of -casein, facilitating binding of the substrate.
4.4. Substrate binding
Significant experimental challenges are associated with
determining the structure of chymosin with a bound inhibitor,
but in 1998 Groves and coworkers succeeded in preparing and
determining the structure of bovine chymosin with a bound
inhibitor (Groves et al., 1998). This structure revealed that a
rigid-body movement of the two domains relative to each
other took place upon binding, similar to that observed for
other aspartic peptidases (Sˇali et al., 1992). In addition, Tyr77
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undergoes a conformational change in bovine chymosin that
enables the substrate to enter the binding cleft, as described
previously by Gilliland et al. (1990) and Newman et al. (1991).
Andreeva et al. (1992) have previously identified residues that
may influence the mobility of Tyr77, and as they are virtually
identical in bovine and camel chymosin we conclude that the
improved milk-clotting properties of camel chymosin are
unlikely to be related to a change in the mobility of Tyr77.
Chen et al. (1992) studied the structure of the pepstatin–
pepsin complex and showed a correlation between the domain
movement and the size of the bound inhibitor (Groves et al.,
1998). In view of the differences in secondary structure
between bovine and camel chymosin described above, one
would expect camel chymosin to be more flexible, with a
greater ability to accommodate substrates and inhibitors of
different natures.
The hydrogen-bonding network that positions the Asp34
and Asp216 catalytic machinery is identical in bovine and
camel chymosin, and it seems unlikely that it would be
affected by structural variations of the substrate-binding cleft.
The inhibitor structure determined by Groves et al. (1998)
mapped out subsites S4 to S10 of bovine chymosin. This
information has enabled us to identify the residues delineating
the substrate-binding site that differ between bovine and
camel chymosin and that may affect the specific binding of the
substrate (Table 4). The S1 and S10 subsites are relatively large
and hydrophobic, as observed for most aspartic peptidases
(Kay & Dunn, 1992), and seem to be well suited to accom-
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Figure 5
The substrate-binding clefts of bovine (a, c) and camel (b, d) chymosin. The active-site residues and the activated water molecule are illustrated in red.
Residues 11–16 of camel chymosin are shown in magenta. Glycerol (Gol1334) and the residues that differ between bovine and camel chymosin are shown
in green (Table 4). (a) and (b) illustrate the loops that form the entrance to the binding site. (c) Subsite S1 with Leu32 and subsites S2 and S4 with Lys221
and Val223. (d) The corresponding subsites in camel chymosin with Val32 (both conformations) and with Val221 and Phe223, respectively.
modate the side chains of Phe105 andMet106 of -casein. The
additional electron density that was found in the active site is
located in subsite S10 and was modelled as glycerol. Although
the exact nature of the bound molecule is unknown and it does
not appear to make any hydrogen bonds to the surrounding
protein residues, it shows that subsite S10 possesses a
propensity for binding smaller molecules. In a mutational
study of chymosin in which Val111 (which forms part of S1 and
S3) was mutated to Phe (the corresponding residue in pepsin)
the enzyme showed a significant decrease in activity related
to the decreased substrate affinity (Strop et al., 1990). In this
respect, it is interesting to note that Leu32 in bovine chymosin
is replaced by Val in the camel enzyme, which creates a slightly
larger S1 subsite. A minor difference in subsite S3 (binding
Leu103) is the replacement of Ala117 in the bovine enzyme by
Ser in camel chymosin. More remarkable differences between
the residues delineating the substrate-binding cleft of bovine
and camel chymosin are observed for binding sites S2 and S4
(which bind Ser104 and His102, respectively), in which the
substrate may interact with Lys221 and Val223 in bovine
chymosin, which are replaced by Val221 and Phe223 in camel
chymosin (Fig. 5). These changes influence the shape, volume
and charge of the substrate-binding site. Recent molecular-
modelling studies have also indicated that these residues play
a role in substrate binding. Palmer et al. (2010) studied bovine
chymosin and suggested that Lys221 interacts with the
uncharged His102 of -casein and that Val223 does not take
part in substrate interactions at pH 6.65 (the normal milk-
clotting conditions). In similar modelling investigations of
camel chymosin, Sørensen et al. (2011) proposed that the large
aromatic Phe223 interacts with Ser104 and His102. However,
structure determinations of other aspartic peptidases with
bound inhibitors (Epps et al., 1990; Hong et al., 2000), which
have revealed a great ability to adjust the binding site to the
different inhibitors, do not lend support to the role of His102
proposed from the modelling studies. The observed malle-
ability of substrate binding in aspartic peptidases suggests that
the substrate may show variations in binding to subsites S4 to
S2 between bovine and camel chymosin. The finer details of
the substrate binding can therefore only be revealed by
knowledge of the structure of chymosin with bound substrate
(inhibitor). Our structural comparison of bovine and camel
chymosin suggests that differences in surface charge can
facilitate the binding of camel chymosin to -casein. Unfor-
tunately, computational methods for proteins have not yet
reached a state that enables the modelling of the interactions
of an entire casein micelle with chymosin.
Following the promising industrial applications of camel
chymosin first reported by Kappeler et al. (2006), we have
aimed to identify the structural origins of the improved clot-
ting of bovine milk by camel chymosin compared with bovine
chymosin. Taking the complexity of the natural substrate
casein into consideration, we find that the improved milk-
clotting activity of camel chymosin can be attributed to
variations in the surface charge that facilitate the association
between camel chymosin and the casein micelles. In addition,
the increased mobility of camel chymosin, combined with
significant differences in the residues that delineate the
substrate-binding cleft, contribute to improved substrate
binding by camel chymosin.
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